P F
1 Abr, 2024

Policies recently reviewed for annual update

The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com:

  • Anastomosis of Extracranial-Intracranial Arteries 
  • Blood Product Molecular Antigen Typing 
  • Breast Ductal Lavage for Detection of Breast Cancer
  • CA 125
  • Cardiointegram 
  • Cochlear Implants 
  • Dental Procedures in the Outpatient Setting
  • Disposable Negative Pressure Wound Therapy
  • Dynamic Posturography 
  • Electrogastrography (EGG)
  • Electrical Stimulation and Electromagnetic Therapy for Wound Treatment
  • Endometrial Ablation
  • Home Uterine Activity Monitoring
  • Implantable Bone-Conduction and Bone-Anchored Hearing Aids 
  • Implantation of Intrastromal Corneal Ring Segments
  • Ingestible pH and Pressure Capsule
  • In Vitro Chemoresistance and Chemosensitvity Assays
  • Long Term Acute Care Hospital (LTACH)
  • Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular Risk 
  • Microvolt T-Wave Alternans Testing 
  • Minimally Invasive Coronary Artery Bypass Graft Surgery
  • Monitored Anesthesia Care for Gastrointestinal Endoscopic Procedures 
  • Non-Contact Ultrasound Treatment for Wounds
  • Nutrient-Nutritional Panel Testing 
  • Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
  • Oral Nutrition Mandate
  • Pediatric Dental Services - Essential Health Benefit 
  • Percutaneous Electrical Nerve Stimulation, Percutaneous Neuromodulation Therapy, and Restorative Neurostimulation Therapy
  • Phototherapeutic Keratectomy
  • Phototherapy for the Treatment of Seasonal Affective Disorder 
  • Phototherapy in the Home for the Treatment of Dermatological Conditions
  • Recombinant and Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non-Orthopedic Conditions
  • Scanning Computerized Ophthalmic Diagnostic Imaging 
  • Semi-Implantable and Fully-Implantable Middle Ear Hearing Aid - Insertion 
  • Serum Biomarker Human Epididymis Protein 4
  • Signal-Averaged Electrocardiography (SAECG)
  • Skin Contact Monochromatic Infrared Energy as a Technique to Treat Cutaneous Ulcer, Diabetic Neuropathy and Misc Musculoskeletal Conditions 
  • Sympathetic Therapy for the Treatment of Pain
  • Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic Hyperplasia
  • Thermal Capsulorrhaphy as a Treatment of Joint Instability
  • Thoracic Lumbosacral Orthosis with Pneumatics 
  • Topographic Brain Mapping
  • Transanal Radiofrequency Treatment of Fecal Incontinence
  • Transpupillary Thermotherapy for Treatment of Choroidal Neovascularization

We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the “Draft Medical Policies" drop-down.